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Abstract
Background: It is commonly believed that the pathophysiology of obesity arises from adiposity.
In this paper, I forward a complementary explanation; this pathophysiology arises not from
adiposity alone, but also from the psychological stress induced by the social stigma associated with
being obese.
Methods: In this study, I pursue novel lines of evidence to explore the possibility that obesity-
associated stigma produces obesity-associated medical conditions. I also entertain alternative
hypotheses that might explain the observed relationships.
Results: I forward four lines of evidence supporting the hypothesis that psychological stress plays
a role in the adiposity-health association. First, body mass index (BMI) is a strong predictor of
serological biomarkers of stress. Second, obesity and stress are linked to the same diseases. Third,
body norms appear to be strong determinants of morbidity and mortality among obese persons;
obese whites and women – the two groups most affected by weight-related stigma in surveys –
disproportionately suffer from excess mortality. Finally, statistical models suggest that the desire
to lose weight is an important driver of weight-related morbidity when BMI is held constant.
Conclusion: Obese persons experience a high degree of stress, and this stress plausibly explains
a portion of the BMI-health association. Thus, the obesity epidemic may, in part, be driven by social
constructs surrounding body image norms.
Background
Over the past two decades, body mass has increased rap-
idly, especially among persons who are already over-
weight or obese.[1] This increase in body mass presents
public health challenges both because thin bodies are
seen as physically attractive, and because obesity is associ-
ated with poor health outcomes.[2,3] Obese persons'
health is worse throughout the lifecourse than normal
weight persons, and their lifespan is nearly two years
shorter on average.[2]
The conventional wisdom is that this obesity-related
excess mortality arises from a series of biochemical
changes associated with adiposity. [4-14] These changes
include higher serum levels of pro-inflammatory, pro-
thrombotic cytokines, such as C-reactive protein (CRP),
tumor necrosis factor alpha (TNF-alpha), and interleukin-
6 (IL-6).[15] Cytokines serve as messenger molecules that
mobilize the immune system, increase vascular tone, and
enhance the formation of blood clots. Most of these latter
functions offer a huge survival benefit when an organism
is threatened with injury. However, cytokines can also
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have harmful effects when serum levels remain chroni-
cally elevated, including an increased risk of diabetes,
hypertension, heart disease, and immune dysfunc-
tion.[16]
The idea that adipose cells either secrete these biochemi-
cal mediators or induce other cells to secrete them has
been called the adiposity hypothesis.[10,13,17] In addi-
tion to elevated cytokine levels, a wider array of auto-
nomic and hormonal dysfunction has been observed in
obese persons, and this dysfunction also plausibly con-
tributes to obesity-associated morbidity and mortal-
ity.[17]
Nevertheless, some scientists suggest that researchers have
incited a "moral panic" over the obesity epidemic without
forwarding sufficient proof that obesity causes poor
health.[18,19] They argue that there is certainly a strong
correlation between adiposity and poor health, but that
this correlation is not causal. They point to phenomena
that cannot be readily explained by the adiposity hypoth-
esis. For instance, overweight people who are not obese
suffer less morbidity and mortality than normal weight
people.[3] Moreover, some groups, such as obese African
Americans, do not suffer from excess mortality the same
way that obese whites do.[20,21] More troubling, there is
no direct evidence that expanded adipose cells themselves
actually secrete sufficient quantities of biochemical medi-
ators to explain the additional burden of disease suffered
by obese persons.[13]
There is also a complementary explanation for the associ-
ation between obesity and the presence of higher serolog-
ical levels of pro-inflammatory, pro-thrombotic
cytokines; the stigma associated with obesity could
explain the higher serum levels of these very mediators.
[22-24] Psychological stress causes general autonomic
activation. When chronic, as in the case of stigma, post-
traumatic stress disorder (PTSD), or low socioeconomic
status, stress may disrupt the homeostatic mechanisms
that check the levels of the same cytokines that have been
observed to be elevated in obese persons.[16,17,25,26]
This disruption of homeostatic systems has been hypoth-
esized to lead to a new set point for these mechanisms in
a phenomenon called allostatic load. In most chronically
stressed individuals, this set point is higher, leading to ele-
vated levels of these biochemical stress mediators. [26-29]
Allostatic load may explain higher rates of these mediators
seen in a wide array of groups experiencing psychological
stress, such as African-Americans who experience racial
discrimination on a daily basis.[30]
Likewise, obese persons report extremely high levels of
stigmatization and discrimination; among one group of
formerly obese persons asked to choose between blind-
ness or obesity, 89% chose blindness.[31] Discrimination
is also pervasive; there is evidence that parents discrimi-
nate against their obese children, doctors against their
obese patients, and husbands against their obese
wives.[32,33] All things otherwise equal in childhood,
heavy people are less likely to reach milestones of social
success, including completing schooling, finding a
romantic partner, and garnering a good job.[34] As a
result, obese persons are more likely to suffer from a neg-
ative self-image than thinner persons.[18,33,34]
In this paper, I explore the possibility that the stress asso-
ciated with social stigma and negative body image among
obese persons explains some of the weight-associated
morbidity that researchers had previous attributed to adi-
posity alone. I will critically re-examine the scientific liter-
ature and draw upon my own research to explore
interlocking lines of evidence supporting the proposed
obesity-related stigma hypothesis. After a brief review of
the conceptual framework of the paper, I will go into each
of the lines of evidence supporting my hypothesis in
detail. I will conclude with a brief discussion of the policy
implications of this hypothesis and the limitations of the
analytical framework I present.
Conceptual framework
To my knowledge, this paper forwards the first examina-
tion of stigma-induced psychological stress as a putative
etiologic agent in the pathophysiology of obesity. In
assembling this paper, it was therefore necessary to think
through various ways in which psychological stress might
be shown as a contributor to morbidity and mortality. To
do so, I examined four lines of evidence suggesting that
stigma-induced stress mediates the relationship between
obesity and health.
First, I re-examine studies embedded in the adiposity liter-
ature as well as studies from the literature on socioeco-
nomic status-induced stress and health (in which BMI was
included as a covariate). While metabolic studies of obes-
ity simply measure serum levels of cytokines and other
compounds, studies examining socioeconomic status-
induced stress tend to stress subjects in a laboratory set-
ting. In doing so, they provide a more direct measure of
how being obese or thin modifies the normal human
stress response.[10,11,28] The socioeconomic status liter-
ature also contributes by using much larger, nationally
representative samples.[35,36] Finally, body mass index
plays a prominent role in some of the more groundbreak-
ing stress studies, including those linking stress to markers
of premature biological aging.[37] However, it is difficult
to ascertain causality from these simple associations; BMI
may be inducing the stress response, adipose tissue may
be producing the stress mediators, BMI may be a con-
founder, or stress may lead to an increase in BMI.[16]BMC Public Health 2008, 8:128 http://www.biomedcentral.com/1471-2458/8/128
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Second, to better tease these factors apart, I and a team of
researchers sought to ascertain whether it was one's BMI
or one's satisfaction with his or her weight that was most
important in the relationship between adiposity and
health.[38] To do this, we used the 2003 Behavioral Risk
Factor Surveillance System dataset, which contains a ques-
tion asking subjects to place a numerical value on their
desired body weight. In analyzing these data, we found
that the difference between a subject's desired body
weight and his or her actual body weight (a measure that
captures the psychological dimensions of obesity) is a
much more powerful predictor of morbidity than is BMI
(a measure that captures the physiological dimensions of
obesity).
Third, to be reasonably certain that stigma-induced psy-
chological stress plays a significant role in BMI-associated
mortality, we would expect to see overlap in the causes of
death due to obesity and stress. As it turns out, the condi-
tions associated with the stress response – hypertension,
heart disease, type II diabetes, and hypercholesterolemia
– are the very conditions associated with obesity.[6,16]
Finally, if stigma plays a major role in the association
between obesity and health, we would expect less stigma-
tized groups to have less obesity-associated morbidity. As
it turns out, younger persons, whites, and women are dis-
proportionately affected by negative body image concerns
arising from sub-group norms, and these same groups dis-
proportionately suffer from BMI-associated morbidity
and mortality.[2,21,39,40]
In short, I test my hypothesis that the stress produced by
obesity-related stigma plays a major role in the patho-
physiology of obesity using four very different conceptual
approaches. This framework provides the reader with a
gestalt of the interlocking evidence supporting the obes-
ity-related stigma hypothesis. In the following sections, I
will focus on each line of evidence in detail. I will briefly
discuss less-developed forms of evidence requiring further
development. I will then conclude with a discussion of the
limitations of the analysis, and evidence countering the
proposed hypothesis.
Results
The endocrinology of stress and obesity
Adipose tissue as an endocrine organ
Obese persons have higher serum levels of molecular
compounds that promote blood clotting and inflamma-
tion.[7,10,11,13,35] This is true even after controlling for
fat consumption, age, gender, race, smoking, income and
medication use.[35] When serum levels of such com-
pounds (e.g., cytokines) remain elevated for extended
periods, permanent physiological changes can occur that
disrupt homeostatic function.[6,16] These compounds
are thought to underlie much of the pathophysiology of
obesity.
Visceral fat secretes at least eleven such compounds. [7-
11] However, visceral fat is composed of different types of
tissue and there is considerable debate surrounding
whether adipose cells themselves secrete these com-
pounds.[8,12,13] While adipose cells share a common
lineage with immune cells, they appear to lack the vesicles
needed to actually store and secrete endocrine or para-
crine compounds.[41] It is thought instead that these
compounds are released by immune cells, which tend to
surround or invade fatty tissue.[12,13] Because immune
cells are both activated by the autonomic stress response
and primarily responsible for releasing these compounds
into the serum, it is conceivable that adipose cells play less
of a role in the pathophysiology of obesity than was pre-
viously thought.
The neuroendocrinology of stress
Before exploring hypothetical reasons why fatty tissue
might secrete pro-inflammatory, pro-thrombotic com-
pounds, it is important to consider the function of these
compounds in evolutionary biology.[16] Foremost, these
compounds enhance blood clotting when the body is
injured. They also provide feedback to the autonomic
nervous system, leading to an increase in blood pressure
and heart rate to ensure that the body can escape or fight
a predator.[16,42] Finally, they mobilize the immune sys-
tem to fight off infectious agents that may enter through
broken skin.[16]
The endocrine molecules responsible for this pro-inflam-
matatory, pro-thrombotic response can take critical sec-
onds to fully enter the circulation and reach the area of
injury. Anticipation of threat by the brain therefore plays
a critical role in preparing the body well in advance of any
attack.[22,43,44] For instance, when an animal sees a
predator, the visual information activates emotion and
stress circuits in the brain.[42] These circuits then activate
other neural and endocrine centers that lead to activation
of the fight or flight autonomic nervous system and the
release of hormones, such as cortisol, and cytokines, such
as CRP. Today, most of these threats take the form of
aggressive drivers, controlling bosses, annoying neighbors
or domestic conflict rather than a threat of bodily harm by
a predator.[45,46]
Visceral obesity might therefore increase serological levels
of these mediators via obesity-induced stigma or via direct
secretion. Either way, the resulting biochemical changes
increase one's risk for hypertension, glucose dysregula-
tion, and dyslipidemia.[7-9,16,47] These changes, in turn,
explain the higher rate of diabetes, heart disease, hyper-
tension, and infectious disease.BMC Public Health 2008, 8:128 http://www.biomedcentral.com/1471-2458/8/128
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Competing hypotheses
There are at least three explanations for the association
between adiposity and higher serum levels of molecular
compounds that regulate inflammation and thrombosis.
￿ First, it has been proposed that these physiological
changes in obese persons might occur as a side effect of
the linkage between the immune system and satiety.
Immune system maintenance consumes 15% of the
body's daily energy needs.[48] When injured, stressed, or
starved, the body must divert energy to tissue repair and
shut down all functions that are not critical for survival.
When well fed, levels may naturally rise.
￿ Second, it is possible that high stress individuals become
obese as a result of excess cortisol levels and stress-
induced overeating.[49] If this is the case, then stress
causes obesity, rather than the other way around.
￿ Finally, it is possible that the psychological stress associ-
ated with the social stigma of being overweight or obese
leads to a physiological stress response.[2,38]
It is likely that all three hypotheses are correct. For
instance, higher serum cortisol is known to increase cen-
tral obesity.[49,50] However, because weight loss appears
to reduce the circulating levels of pro-inflammatory medi-
ators, this cannot be the sole explanation for higher serum
levels of mediators in obese persons.[17] Likewise, there
is good evidence that rats, which are presumably free of
obesity-related social stigma, produce higher levels of
these compounds when overfed to the point that they
become obese. Finally, obese persons experience discrim-
ination, and stigma-induced psychological stress is a well-
described phenomenon.[16,35,51] It would thus be sur-
prising if stigma were not a contributor to obesity-associ-
ated morbidity.
Evidence from the stress literature
The stress literature has not yet focused on obesity. How-
ever, BMI is often included as a covariate in regression
analyses examining the association between stigma and
stress or socioeconomic status and stress.[28,35,36,52]
This literature contributes to the debate because subjects
are often tested for stress reactivity, a measure of allostatic
load. Allostasis, or a shifting of the body's endocrinologic
thermostat, likely happens in the brain rather than fatty
tissue. Therefore, evidence of stress reactivity among obese
persons would be suggestive of a link between stigma-
induced stress and obesity-associated morbidity.
One common approach to measuring the stress response
in the stress literature is to administer a stressful task, and
then measure changes in the autonomic response, sero-
logical levels of cytokines, or changes in cortisol response
(via any step in the hypothalamic-pituitary-adrenal
axis).[28,52] In these studies, blood samples are collected
at baseline and post-task. Where measured, BMI is usually
among the most important predictors of significantly
greater autonomic activation and cytokine production.
This suggests that allostatic load may play a role, and may
lend evidence to the hypothesis that some obesity-associ-
ated illness arises from perceived stigma. If so, it is useful
to examine how variations in perceived stigma might
explain variations in physiological responses among
obese persons.
Body preferences and the distribution of disease
Body norms differ by gender, race, ethnicity, age, and soci-
oeconomic status.[38-40,53,54] For instance, heavier
women are more likely to have a negative body image
than heavier men. Likewise, white race, young age, high
income, and high educational attainment are all predic-
tors of body dissatisfaction among overweight persons.
Conversely, overweight African-Americans, Hispanics,
young persons and men all tend to be more comfortable
with their bodies when they are overweight or obese.
If perceived stigma is responsible for some of the obesity-
associated morbidity and mortality, differences in body
size preferences by social class, age, race, and gender
should translate into differences in morbidity and mortal-
ity. In the following sections, I will review patterns of
excess morbidity and mortality among overweight and
obese persons by gender, race, and age.
Gender and weight-related health
Women are seven times as likely as men to experience
excess quality-adjusted life years (QALYs) lost to being
overweight.[2] (A QALY is a measure that combines mor-
bidity and mortality, with one QALY equal to one year of
perfect health.) These effects are seen both for broad
measures of health, as well as for specific diseases, such as
depression.[21,55]
In a comprehensive burden of disease analysis by gender,
I collaborated with a research team to analyze the Medical
Expenditure Panel Survey (MEPS).[2] The objective was to
ascertain both the morbidity and mortality effects of
being overweight (BMI > 25 to ≤ 30) or obese (BMI > 30)
by gender. The MEPS is a large, nationally representative
survey that contains a health-related quality of life instru-
ment, which can be used to estimate QALYs. This instru-
ment, the EuroQol, measures "health" with respect to
mobility, self-care, activity limitations, anxiety/depres-
sion, and pain/discomfort. Thus, it captures the extent to
which people are anxious or depressed about their weight
as well as any impacts obesity might have on other aspects
of their physical health.BMC Public Health 2008, 8:128 http://www.biomedcentral.com/1471-2458/8/128
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We found that younger overweight and obese women
tend to be much less healthy than normal weight women
up to around age 45. However, despite their poorer
health, heavier young women experience similar or even
lower numbers of deaths as normal weight women in this
age group. Much of this excess morbidity among younger
overweight women may be psychological, taking the form
of anxiety and depression.[55] After age 45, excess mor-
bidity declines and excess deaths begin to rise (Figure 1).
This pattern roughly fits with a stress-based model of dis-
ease; both race-associated stigma and the stressors associ-
ated with low socioeconomic status show a similar
pattern of excess morbidity and mortality. [56-58]
Race and weight-related health
As might be predicted by the distribution of negative body
image, whites suffer from excess mortality at a much lower
BMI than African-Americans.[21] In Figure 2, we see that
white men and women begin to experience excess loss of
life at a BMI of typical of overweight persons (BMI > 25 to
≤ 30). For African-Americans, being overweight is protec-
tive among both men and women. Moreover, obesity
(BMI ≥ 30+) is associated with excess years of life lost only
among younger African-Americans.
In fact, African-American women who have a BMI of 30 to
37 suffer fewer excess years of life lost than normal weight
African-American women across all age groups. Moreover,
African-American women do not experience excess mor-
tality unless they are less than 60 years of age and over a
BMI of 37. If adiposity is a health risk in this group, there
must be a very powerful factor driving survival among
overweight African-American women. This is unlikely to
be socioeconomic status, given that low-income African-
American women are more likely to be overweight than
high-income African-American women.[56]
Age and weight-related health
There has been a long-term trend toward negative body
image among heavier females.[59] Fuller-figured models
were still preferred in the World War II era, with thin bod-
ies possibly signifying inadequate nutrition.[60] How-
ever, as the economy gained distance from the depression
era, thin bodies may have come to signify membership in
the leisure class. World War II generation women appear
to be somewhat spared from these effects; women in the
65 and over age range report less negative body image and
experience less excess morbidity or mortality than
younger women.[21]
It is possible, however, that this represents little more than
a generic survival effect. If so, we would expect to see less
survival effect by age among older African-American
females (since this group experiences less mortality than
whites at younger ages). However, even morbidly obese
elderly African-American women have fewer excess years
of life lost than their "normal" weight peers (Figure 2).
Mortality data by gender, race, and age strongly support
the hypothesis that sub-group norms surrounding body
image have a strong influence on premature mortality.
However, they also raise some questions. For one, we do
not know how socioeconomic status influenced the
observed rates. While poor body image is positively asso-
ciated with income and educational attainment, BMI is
negatively correlated with these variables.[2] This would
suggest that the observed effects are stronger than the
graphs show, but it also demonstrates the complexity of
such an analysis, and the potential for confounding. We
would want to see more direct evidence that discord
between one's desired weight and one's actual weight is a
predictor of morbidity and mortality.
BMI versus desired weight
Consider that it is weight dissatisfaction that is driving the
relationship between BMI and health, and that BMI is a
spurious confounder. If so, then it should be possible to
Relationship between excess years of life lost to mortality  (YLLs) and excess morbidity (HRQL) among overweight  (BMI 25–30) and obese (BMI 30+) women by age Figure 1
Relationship between excess years of life lost to mor-
tality (YLLs) and excess morbidity (HRQL) among 
overweight (BMI 25–30) and obese (BMI 30+) women 
by age. In both weight categories, women suffer cumulative 
increases in excess morbidity (both psychological and physio-
logical) until they reach their 30s, at which point, excess 
mortality increases.BMC Public Health 2008, 8:128 http://www.biomedcentral.com/1471-2458/8/128
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Life years lost by body mass index, age, and race Figure 2
Life years lost by body mass index, age, and race. (Figure from Fontaine et al, 2003, used with permission.).BMC Public Health 2008, 8:128 http://www.biomedcentral.com/1471-2458/8/128
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design a study that measures subjects' weight satisfaction,
BMI, and health status.[38] One could then ascertain the
relative contribution of BMI and body weight satisfaction
to health status to ascertain which exerts more of an effect.
The 2003 Behavioral Risk Factor Surveillance System
(BRFSS) provides the opportunity to conduct just such an
analysis. This dataset is based on a telephone survey of
over 247,000 persons nationwide. Key outcome measures
in the BRFSS include the number of physical or mental
"unhealthy days" experienced in the past month. The
2003 BRFSS contains information both on subjects'
reported BMI and their desired body weight. The latter is
measured with the question, "How much would you like
to weigh?" The difference between the desired weight and
actual weight is a relatively straightforward measure of
one's desire for a thinner body.
In this study, all subjects who were below a BMI of 23
(approximately the mid-point of the "normal" range)
were removed to ensure that no anorexic subjects were
included.[38] Separate models were built by gender and
race.
The findings in this analysis were also consistent with the
obesity-related stigma hypothesis; the desire to lose
weight is a much stronger predictor of morbidity than
actual BMI in all models. Moreover, the relationship is
stronger for women than men, and for whites than Afri-
can-Americans or Hispanics. Again, this is consistent with
data from body image surveys.[40]
Controlling for BMI and age, males who wish to lose 1%,
10% and 20% of their body weight suffer a net increase of
0.1, 0.9, and 2.7 total unhealthy days per month. For
females, the corresponding numbers are 0.1, 1.6, and 4.3
total unhealthy days per month. In some models, a higher
BMI is predictive of fewer unhealthy days than a lower BMI
once the relative desire to lose weight is controlled for.
This finding potentially explains the survival advantage
seen among some overweight or moderately obese groups
in the medical literature.[21] If some groups see being
overweight in a positive way, it may confer a survival
advantage. It has also been hypothesized that overweight
persons are more likely to be screened for diabetes and
hypercholesterolemia than normal weight persons and
that this explains the improved survival.[61] However,
this would not explain why overweight African-Americans
are at a significantly greater survival advantage than over-
weight whites, since whites have better access to medical
care. It is also simply possible that overweight people get
a better cardiovascular workout doing day-to-day activi-
ties than normal weight persons. In short, being moder-
ately overweight may be healthy, but it is those groups
that tend not to see fat as unattractive realize health bene-
fits.
If a distorted body image leads to stress and thus morbid-
ity, we would expect that young males who see themselves
as too skinny would also suffer.[62] In post-publication
analyses, Rufina Lee and Marilyn Sinkowitz of Columbia
University, explored whether the desire to gain weight
also predicted greater physical and mental unhealthy days
among young males. Here, too, a measure of distorted
body image – in this case, the desire to gain weight – was
correlated with psychological and physiological morbid-
ity among males aged 18 to 30 (unpublished results).
These data provide compelling support to the hypothesis
that stigma plays a contributing role in the health prob-
lems associated with the obesity epidemic. However, it is
also possible that society's heightened awareness of the
health risks associated with obesity explain the effects
observed in this study. For instance, some subjects may
wish to lose weight simply because they were previously
diagnosed with hypertension, heart disease, or some other
condition for which weight is thought to be a risk factor.
If so, the observed association between the desire to lose
weight and physical unhealthy days could be due to pre-
existing conditions.
Other lines of evidence
In this section, I will briefly describe some other areas of
research that show promise, but require further explora-
tion. The first is the case of Mauritania. Mauritania so val-
ues heavy women that girls are often force-fed at a young
age and are often administered steroids, such as pred-
nisone, to gain weight. This country is currently in the
lowest prevalence category for diabetes.[63] However,
very little is known about the distribution of diabetes
within the population. Most importantly, it would be
helpful to have data on subjects that became overweight
without the help of glucocorticoids, which can alter the
risk of diabetes. It would also be helpful to have data on
temporal trends. Specifically, it would be useful to
observe whether, as the country is increasingly exposed to
North American and European cultural norms, fat is stig-
matized. If so, we may expect acculturation from the west
to lead to a diabetes epidemic in this country. It would be
equally useful to compare "metrosexuals," straight urban
males who tend to be concerned about their appear-
ance,[64] to other males.
The second area that requires further exploration is the
relationship between outward appearance and actual
body fat. We do know that visceral body fat predicts
pathophysiology, but that subcutaneous body fat does
not.[9,65] It is plausible that visceral body fat causes moreBMC Public Health 2008, 8:128 http://www.biomedcentral.com/1471-2458/8/128
Page 8 of 10
(page number not for citation purposes)
body shape distortion, and therefore more concern over
the changes in one's body.
Likewise, persons who are "big boned," or broad in form
can appear fat even when they are actually lean. Such per-
sons will also have an artificially elevated BMI. Thus, BMI
may be a better predictor of whether people appear fat
than it is of their actual total body fat.
Bioelectrical impedance analysis (BIA) is a highly accurate
measure of total body fat that is not readily apparent to
the naked eye. If adiposity explains the relationship
between BMI and health, we would expect BIA to be a bet-
ter predictor of obesity-associated conditions than BMI.
Here, too, it appears as if BMI is a stronger predictor of
obesity-associated conditions than BIA.[66] Thus, if body
shape and size were more important than actual body fat
in determining pathophysiology among obese persons,
we would expect that stigma-induced stress is again a
potential culprit. However, more detailed analyses are
needed. For instance, it would be helpful to control for
variance in body fat distribution by age, race, and gender
and to have a more concrete measure of perceived body
image in BIA studies.
Conclusion
It is important to understand the role that stigma plays in
producing disease amongst overweight and obese persons
for many reasons. Foremost, the assumptions surround-
ing the pathophysiology of overweight and obesity could
be partially incorrect. Second, if stigma-induced stress
plays a role in the pathophysiology of obesity, it suggests
that social constructs of idealized body image can have
harmful health effects. If so, it raises pragmatic questions
surrounding the net health benefits of public health com-
munications campaigns, which often promote thinness.
Finally, overweight and obesity are associated with over 7
million QALYs annually in the U.S., potentially making it
one of the major causes of death.[2]
Nonetheless, the evidence I appraise here is far from con-
clusive. First, there is evidence that fatty tissue does have
metabolic function. This is true not only of steroid pro-
duction and function,[47] but may also be true of
cytokine production. [4-13] Further work in this area will
help clarify the relationship between immune tissue and
fatty tissue in the production of pro-inflammatory and
pro-thrombotic mediators.
Complementary hypotheses also exist. For instance, there
is strong evidence that stress increases the risk of central
obesity.[49,50] Thus, there is not only room for con-
founding in some of the data I discuss, but the findings are
partially explained by reverse causality. As discussed
above, reverse causality can only play a limited role, since
dieting can reverse the metabolic effects of obesity.[17]
However, neither hypothesis explains why a discrepancy
between one's perceived ideal weight and his or her actual
weight is a stronger predictor of morbidity than BMI.[38]
Nor do they explain why differences in body image norms
among different racial and ethnic groups appear to be
strong predictors of obesity-related mortality.
There are other reasons why the obesity-induced stigma
hypothesis cannot explain all of the association between
obesity and morbidity. For instance, there is evidence that
adiposity is independently linked to some obesity-related
illnesses.[67] In particular, there is a link between internal
obesity, which is less visible, and the metabolic syndrome
in Asians.[68] This suggests that genes, developmental
environment, or reverse causality play a role in this group.
Moreover, genetic makeup in general might simultane-
ously affect one's propensity to gain weight as well as his
or her physiologic response to being overweight.[69] Nev-
ertheless, the obesity-related stigma hypothesis is logical
and complements, rather than refutes, the adiposity
hypothesis.
There are certainly conditions and illnesses that can be
clearly attributed to obesity. One of these is sleep apnea,
which has also been linked to metabolic disruptions.[70]
Sleep deprivation has also been linked to excess stress
mediator production in high stress populations, such as
persons of low socioeconomic status. This highlights the
many psychophysiological pathways at work in produc-
ing obesity-associated morbidity.
One final concern is that a wide array of other complex
psychosocial factors contributes to obesity-associated
morbidity and mortality, and it is difficult to tease them
apart. For instance, stress can reduce cognitive function
via damage to the hippocampus (a region of the brain
important in memory), potentially contributing to heavy
persons' lower educational attainment.[71,72] Lower
educational attainment, in turn, may explain some of the
health and longevity effects of obesity. Likewise, stress can
play a role in obese persons' higher incidence of smoking.
Like stress, smoking is associated with dyslipidemia,
atherosclerosis, and elevated CRP levels.
In developing nations where food is scarce, obesity might
be seen as a proxy measure for affluence (and thus domi-
nance in social hierarchies). As nations industrialize,
however, cheap, calorie-dense food becomes plentiful
and leisure time becomes scarce. Thus, thinness replaces
plumpness as a proxy measure for affluence. By looking at
case studies such as Mauritania, which still values plump-
ness, we should be able to observe an increase in obesity-
associated pathophysiology that is coincident with shifts
in depictions of beauty in the media.BMC Public Health 2008, 8:128 http://www.biomedcentral.com/1471-2458/8/128
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If shifts in depictions of beauty in the media are partially
to blame for the health effects of obesity, public health
officials may have unwittingly exacerbated the problem
by promoting thinness. This paper's hypothesis thus
speaks to larger examinations of public health policy, and
health communications campaigns. If the obesity epi-
demic is partially attributable to social constructs sur-
rounding ideal body types, there is a need for new
research and policy paradigms that emphasize fitness and
healthy eating habits[73] alongside social acceptance of
heavier members of society.
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